Clinical Trials Directory

Trials / Completed

CompletedNCT05529030

COVID-19 Booster Readiness Survey

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12,036 (actual)
Sponsor
Geisinger Clinic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this administrative survey is to inform health system logistics by assessing the attitudes towards towards the bivalent COVID-19 boosters held by healthcare workers (HCWs) at a large, rural health system. It will also test, prospectively, the effect on interest in the bivalent COVID-19 booster of different framing approaches in a survey question sent to employees of a large, rural health system.

Detailed description

The Food and Drug Administration has authorized two bivalent COVID-19 boosters with the expectation that the Centers for Disease Control will soon recommend them. The researchers plan to survey the HCWs at a large, rural health system on their attitudes on the bivalent booster. This survey will gather data on HCWs' interest in a bivalent booster, reasons for hesitancy, risk perception about COVID-19 infection and its complications, and prior COVID-19 infection and vaccination. Respondents will also be randomly assigned to see different versions of the question asking if they are interested in a bivalent booster with different framing approaches, such as protection of the self or protection of patients (for patient-facing employees). Information on prior vaccination and perceptions of risk will also be gathered and used as covariates in the analysis.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSalience of Omicron variantThe message mentions the Omicron variant, which can be a fear appeal or make salient the reason for the new booster
BEHAVIORALSelf-protection messageThe message makes a reference to protecting one's self
BEHAVIORALOther-protection messageThe message makes a reference to protecting others (patients)

Timeline

Start date
2022-09-01
Primary completion
2022-09-15
Completion
2022-09-15
First posted
2022-09-06
Last updated
2022-09-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05529030. Inclusion in this directory is not an endorsement.